Company Overview of Stemgent, Inc.
Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company offers a set of tools for generating induced pluripotent stem (iPS) cells, as well as small molecules, non-viral and viral reprogramming technologies, transfection reagents, cytokines, cell lines, antibodies, and cell culture media. Its products include antibodies for live staining of ES/iPS cells; purified and conjugated antibodies; alkaline phosphatase kits; XF/FF medium and cell culture reagents of human ES/iPS cells; WIT media system for breast cancer research; human fibroblast cell line for the generation of iPS cells; characterized mouse primary iPS cell lines; high-purit...
One Kendall Square Street 2
Cambridge, MA 02139
Founded in 2007
Key Executives for Stemgent, Inc.
Director of Sales and Marketing
Compensation as of Fiscal Year 2014.
Stemgent, Inc. Key Developments
Cellectis bioresearch SAS Announces Collaboration with Stemgent, Inc
Mar 7 13
Cellectis bioresearch SAS announced collaboration agreement with Stemgent Inc. to provide research services that combines mRNA reprogramming technology and genome engineering. The partnership marries Cellectis bioresearch's leadership in genome engineering with Stemgent's expertise in cellular reprogramming.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries